Skip to main content
XCUR
NASDAQ Life Sciences

10% Owner Exicure HiTron Inc. Sells $1.16M in EXICURE, INC. Stock

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$6.101
Mkt Cap
$38.884M
52W Low
$3.101
52W High
$15.91
52W Position info
97% above low
Off High info
62% below high
Rel. Volume
Market data snapshot near publication time

XCUR sits 97% above its 52-week low of $3.101.

Summary

Exicure HiTron Inc., a 10% owner of EXICURE, INC., reported an open market sale of common stock valued at over $1.16 million, representing a significant disposition of shares.


Key Events · Ownership and Investor Activity · XCUR

  • 10% Owner Sells Significant Stake

    Exicure HiTron Inc., a 10% owner of EXICURE, INC., sold 258,367 shares of common stock in an open market transaction.

  • Over $1.16 Million in Shares Disposed

    The total value of the shares sold amounted to $1,162,652, representing a substantial disposition by a major shareholder.

  • Transaction Priced Below Current Market

    The shares were sold at $4.50 per share on January 21, 2026, which is below the current stock price of $6.1005.


Analysis · XCUR · Life Sciences

Exicure HiTron Inc., a 10% owner of EXICURE, INC., reported a substantial open market sale of common stock. This disposition, valued at over $1.16 million, represents a significant portion of the company's market capitalization. While the sale is by a financial investor rather than an operational executive, such a large transaction by a major shareholder can be perceived negatively by the market, suggesting a reduction in conviction. Investors should note the sale price of $4.50 per share was below the current market price of $6.1005.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, XCUR was trading at $6.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $38.9M. The 52-week trading range was $3.10 to $15.91. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

XCUR - Latest Insights

XCUR
Nov 10, 2026, 3:50 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.08
Real-time Price: $1.01 info
Change: -$0.071 (-7%) info
Market Cap: $7.07M info
XCUR
Nov 10, 2026, 3:50 PM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.08
Real-time Price: $1.01 info
Change: -$0.071 (-7%) info
Market Cap: $7.07M info
XCUR
Nov 02, 2026, 5:25 PM EST
Filing Type: PRE 14A
Importance Score:
8
Price at Filing: $1.06
Real-time Price: $1.01 info
Change: -$0.050 (-5%) info
Market Cap: $7.07M info
XCUR
Sep 16, 2026, 10:27 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.31
Real-time Price: $1.01 info
Change: -$0.295 (-23%) info
Market Cap: $7.07M info
XCUR
Aug 14, 2026, 3:27 PM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.26
Real-time Price: $1.01 info
Change: -$0.250 (-20%) info
Market Cap: $7.07M info